Analyst Price Targets — BDSX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 10, 2026 9:48 am | Kyle Mikson | Canaccord Genuity | $35.00 | $23.50 | StreetInsider | Biodesix (BDSX) PT Raised to $35 at Canaccord |
| June 24, 2026 8:26 pm | Max Masucci | Roth Capital | $32.00 | $18.67 | TheFly | Biodesix initiated with a Buy at Roth Capital |
| June 18, 2026 10:54 am | Kyle Mikson | Canaccord Genuity | $27.00 | $15.22 | StreetInsider | Biodesix (BDSX) PT Raised to $27 at Canaccord |
| June 15, 2026 10:14 am | — | H.C. Wainwright | $26.00 | $15.06 | TheFly | Biodesix initiated with a Buy at H.C. Wainwright |
| September 19, 2025 11:45 am | — | Canaccord Genuity | $20.00 | $6.69 | TheFly | Biodesix price target lowered to $20 from $30 at Canaccord |
| September 16, 2024 9:03 am | Sung Ji Nam | Scotiabank | $3.00 | $1.82 | TheFly | Biodesix initiated with an Outperform at Scotiabank |
| July 26, 2024 7:17 am | Bill Bonello | Craig-Hallum | $3.00 | $1.68 | StreetInsider | Craig-Hallum Starts Biodesix (BDSX) at Buy |
Latest News for BDSX
Biodesix, Inc. (NASDAQ: BDSX - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the five analysts that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have issued a buy recommendation and one has given a strong buy recommendation to the
LOUISVILLE, Colo., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will present in three upcoming investor conferences:
Does Biodesix, Inc. (BDSX) have what it takes to be a top stock pick for momentum investors? Let's find out.
The consensus price target hints at a 26.7% upside potential for Biodesix (BDSX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Precipio and Biodesix take different approaches to cancer diagnostics, but which stock looks more compelling now? Let's dive in.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BDSX.
U.S. House Trading
No House trades found for BDSX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.